Suvretta Capital Management »

Prokidney Corp Shs Cl A shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Prokidney Corp Shs Cl A (PROK) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Prokidney Corp Shs Cl A

Tip: Access up to 7 years of quarterly data

All positions including Prokidney Corp Shs Cl A held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prokidney Corp Shs Cl A by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $30M 12M 2.42

More positions owned by Suvretta Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Arcutis Biotherapeutics (ARQT)
Benitec Biopharma Com New (BNTC)
Meta Platforms Cl A (META)
Legend Biotech Corp Sponsored Ads (LEGN)
89bio (ETNB)
Immatics SHS (IMTX)
Coca-Cola Company (KO)
Ge Aerospace Com New (GE)
NVIDIA Corporation (NVDA)
Eyepoint Pharmaceuticals Com New (EYPT)
Biohaven (BHVN)
Mineralys Therapeutics (MLYS)
Home Depot (HD)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Suvretta Capital Management

Top funds holding Prokidney Corp Shs Cl A

Suvretta Capital Management
Bleichroeder
Millennium Management
Vanguard Group
BlackRock
Geode Capital Management
Hennion & Walsh Asset Management
Charles Schwab Investment Management
UBS Group
State Street Corporation
Citadel Advisors
MYDA Advisors
Susquehanna International
Squarepoint Ops
Hrt Financial

View all funds holding Prokidney Corp Shs Cl A